BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND MALAT1, PRO1073, 378938, Q9UHZ2
39 results:

  • 1. Knockdown of lncRNA
    Liang T; Lu T; Jia W; Li R; Jiang M; Jiao Y; Wang Y; Cong S; Jiang X; Dong L; Zhou Y; Zhang G; Xiao D
    Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37921054
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The HPV-TP53-malat1 Axis: Unravelling interactions in cervical cancer development.
    Iordanishvili S; Metreveli T; Lipartia E; Gachechiladze K; Khuntsaria I; Qobulashvili T; Jorbenadze M; Revazishvili T; Kldiashvili E; Kaufmann AM
    PLoS One; 2023; 18(10):e0291725. PubMed ID: 37812599
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The involvement of malat1-ALKBH5 signaling axis into proliferation and metastasis of human papillomavirus-positive cervical cancer.
    Wu S; Liu L; Xu H; Zhu Q; Tan M
    Cancer Biol Ther; 2023 Dec; 24(1):2249174. PubMed ID: 37639643
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
    Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
    J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Alteration of Gene and miRNA Expression in Cervical Intraepithelial Neoplasia and Cervical cancer.
    Dudea-Simon M; Mihu D; Pop LA; Ciortea R; Malutan AM; Diculescu D; Ciocan CA; Cojocneanu RM; Simon V; Bucuri C; Mocan-Hognogi R; Braicu C; Berindan-Neagoe I
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682732
    [No Abstract]    [Full Text] [Related]  

  • 6. LncRNA-miRNA-mRNA regulatory axes in endometrial cancer: a comprehensive overview.
    Shetty A; Venkatesh T; Kabbekodu SP; Tsutsumi R; Suresh PS
    Arch Gynecol Obstet; 2022 Nov; 306(5):1431-1447. PubMed ID: 35182183
    [TBL] [Abstract] [Full Text] [Related]  

  • 7.
    Tie W; Ge F
    DNA Cell Biol; 2021 Nov; 40(11):1407-1417. PubMed ID: 34610246
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integrated Bioinformatic Analysis of Competing Endogenous RNA Network of Choriocarcinoma.
    Tan Q; Tan Z; Liu J; Mo Y; Liu H
    Med Sci Monit; 2021 Sep; 27():e931475. PubMed ID: 34538870
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Roles and Mechanisms of the Long Noncoding RNAs in Cervical cancer.
    Cáceres-Durán MÁ; Ribeiro-Dos-Santos Â; Vidal AF
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371204
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression.
    Xia C; Liu C; He Z; Cai Y; Chen J
    J Exp Clin Cancer Res; 2020 Jul; 39(1):127. PubMed ID: 32631421
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MicroRNA-625-5p Sponges lncRNA malat1 to Inhibit Cervical Carcinoma Cell Growth by Suppressing NF-κB Signaling.
    Li Y; Ding Y; Ding N; Zhang H; Lu M; Cui X; Yu X
    Cell Biochem Biophys; 2020 Jun; 78(2):217-225. PubMed ID: 32152961
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. IL-6/STAT3 mediates the HPV18 E6/E7 stimulated upregulation of malat1 gene in cervical cancer HeLa cells.
    Hao Y; Yan Z; Zhang A; Hu S; Wang N; Luo XG; Ma W; Zhang TC; He H
    Virus Res; 2020 May; 281():197907. PubMed ID: 32113834
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Association of polymorphisms in malat1 with the risk of endometrial cancer in Southern Chinese women.
    Chen G; Zhang M; Liang Z; Chen S; Chen F; Zhu J; Zhao M; He J; Hua W; Duan P
    J Clin Lab Anal; 2020 Apr; 34(4):e23146. PubMed ID: 31880028
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. iTRAQ-based quantitative proteomic analysis of the inhibition of cervical cancer cell invasion and migration by metformin.
    Xia C; Yang F; He Z; Cai Y
    Biomed Pharmacother; 2020 Mar; 123():109762. PubMed ID: 31864213
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Alternative splicing of VEGFA is regulated by RBM10 in endometrial cancer.
    Dou XQ; Chen XJ; Wen MX; Zhang SZ; Zhou Q; Zhang SQ
    Kaohsiung J Med Sci; 2020 Jan; 36(1):13-19. PubMed ID: 31587503
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer.
    Han X; Wang Q; Wang Y; Hu B; Dong X; Zhang H; Wang W
    J Cell Physiol; 2019 Aug; 234(8):14170-14180. PubMed ID: 30633360
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Overexpression of malat1 contributes to cervical cancer progression by acting as a sponge of miR-429.
    Shen F; Zheng H; Zhou L; Li W; Xu X
    J Cell Physiol; 2019 Jul; 234(7):11219-11226. PubMed ID: 30515786
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Long non-coding RNAs and cervical cancer.
    Aalijahan H; Ghorbian S
    Exp Mol Pathol; 2019 Feb; 106():7-16. PubMed ID: 30471246
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Association Between malat1 and THRIL Polymorphisms and Precancerous Cervical Lesions.
    Wang Y; Liu Y; Li Z; Yan X; Huang C; Ye X; Sun X; Qin S; Zhong X; Zeng C; Liu D; Zou X; Liu Y; Wu J; Wen Z; Yang G; Jing C; Wei X
    Genet Test Mol Biomarkers; 2018 Sep; 22(9):509-517. PubMed ID: 30188187
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Correlation study between long non-coding RNA malat1 and radiotherapy efficiency on cervical carcinoma and generation of radiotherapy resistant model of cancer.
    Zhu P; Wang FQ; Li QR
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5140-5148. PubMed ID: 30178834
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.